HAL (France)
open access
Hepatitis C: how has France limited the expenses related to new treatments?
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Diagnosis and treatment coverage among hepatitis C infections in Denmark, 2022: a capture-recapture study using national registers#398558
- Incidence of pNeumonia and Related ConseqUences in Nursing Home Residents#1171279
- Changes in Revenues Associated With Antimicrobial Reimbursement Reforms in Germany#309781
- Withholding or Withdrawing of Life-sustaining Therapy in Great East French Region Intensive Care Units: a 1-month Survey#1031196
- Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar#1008172
Record · ID 168465
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive